DARZALEX SC 1800 mg/15 ml, Injektionslösung
7680676890018
CH-67689
Injektionslösung
Associated product:
DARZALEX SC sol inj 1800 mg/15ml flac 15 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
daratumumabum
|
1800.0 MG | Substance | Wirkstoff (Principe actif) |
|
hyaluronidasum humanum ADNr
|
- | Substance | HNIDK |
|
histidinum
|
- | Substance | HNIDK |
|
histidini hydrochloridum monohydricum
|
- | Substance | HNIDK |
|
sorbitolum
|
735.1 MG | Substance | HBESI |
|
methioninum
|
- | Substance | HNIDK |
|
polysorbatum 20
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 4932.10
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2020
Authorization holder
Janssen-Cilag AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 67689
- Drug name
- DARZALEX SC, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- L01FC01
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 13/08/2020
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- DARZALEX SC sol inj 1800 mg/15ml flac 15 ml
- Description (DE)
- DARZALEX SC Inj Lös 1800 mg/15ml Durchstf 15 ml
- Market launch
- 07/09/2020
- Narcotic (BTM)
- No